A Study of Percutaneous Repair of Functional Mitral Regurgitation Using the Ancora Heart, Inc. AccuCinch® Ventricular Repair System - The CINCH-2 Study (CINCH-2)
Sponsor: Ancora Heart, Inc.
This NA trial investigates Functional Mitral Regurgitation and Mitral Regurgitation and is currently completed. Ancora Heart, Inc. leads this study, which shows 15 recorded versions since 2008 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2024 [monthly]
Completed NA
-
Feb 2021 — Sep 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting NA
▶ Show 10 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Aug 2020 — Nov 2020 [monthly]
Recruiting NA
-
Sep 2019 — Aug 2020 [monthly]
Recruiting NA
-
Nov 2018 — Sep 2019 [monthly]
Recruiting NA
-
Aug 2018 — Nov 2018 [monthly]
Recruiting NA
-
Jun 2018 — Aug 2018 [monthly]
Recruiting NA
-
Jun 2017 — Jun 2018 [monthly]
Recruiting NA
-
Apr 2017 — Jun 2017 [monthly]
Recruiting NA
Status: Withheld → Recruiting
-
Feb 2017 — Apr 2017 [monthly]
Withheld NA
-
Jan 2017 — Feb 2017 [monthly]
Withheld NA
First recorded
Nov 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ancora Heart, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .